Literature DB >> 7583936

Heterogeneity of VP4 neutralization epitopes among serotype P1A human rotavirus strains.

J F Contreras1, G E Menchaca, L Padilla-Noriega, R S Tamez, H B Greenberg, S López, C F Arias.   

Abstract

We have used serotype-specific VP4 and VP7 neutralizing monoclonal antibodies (Nt-MAbs), as well as subgroup (SG)-specific MAbs, to characterize by enzyme immunoassay rotavirus strains isolated from diarrheic infants in the city of Monterrey, Mexico, from July 1993 to March 1994. Of a total of 465 children studied, 140 were rotavirus positive, including 3 patients infected with non-group A rotaviruses. The SG and VP7 (G) serotype specificities could be determined for 118 (84%) of the 140 rotavirus-positive stool specimens; 4 rotavirus strains were serotype G1 and SGII; 1 strain was serotype G2 and SGI+II; 112 strains were serotype G3 and SGII; 1 strain was serotype G3 and SGI; and none of the strains was serotype G4. Fifty-eight specimens, representing the 13 different group A rotavirus electropherotypes detected, were chosen for VP4 (P) serotyping. Of these, 48 (83%) strains reacted with the P1A serotype-specific Nt-MAb 1A10. None of the strains reacted with the serotype P2-specific Nt-MAbs tested. Not all viruses that reacted with Nt-MAb 1A10 were recognized by Nt-MAbs 2A3 and 2G1, which also recognize P1A strains, indicating heterogeneity of neutralization epitopes among serotype P1A human rotaviruses. This heterogeneity could be relevant for the specificity of the VP4-mediated neutralizing antibody immune response and indicates the need for antigenic characterization, in addition to genomic typing, of the VP4 proteins of circulating human rotavirus field strains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583936      PMCID: PMC170191          DOI: 10.1128/cdli.2.4.506-508.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  24 in total

1.  Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies.

Authors:  B S Coulson
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

2.  Distribution of VP4 gene alleles in human rotaviruses by using probes to the hyperdivergent region of the VP4 gene.

Authors:  A D Steele; D Garcia; J Sears; G Gerna; O Nakagomi; J Flores
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

3.  VP4 genotyping of human rotavirus in the United States.

Authors:  N Santos; M Riepenhoff-Talty; H F Clark; P Offit; V Gouvea
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

4.  The outer capsid protein VP4 of murine rotavirus strain Eb represents a tentative new P type.

Authors:  M M Sereno; M I Gorziglia
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

5.  Survey on the distribution of the gene 4 alleles of human rotaviruses by polymerase chain reaction.

Authors:  H Wu; K Taniguchi; F Wakasugi; S Ukae; S Chiba; M Ohseto; A Hasegawa; T Urasawa; S Urasawa
Journal:  Epidemiol Infect       Date:  1994-06       Impact factor: 2.451

6.  Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.

Authors:  L Padilla-Noriega; R Werner-Eckert; E R Mackow; M Gorziglia; G Larralde; K Taniguchi; H B Greenberg
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Relative frequency of VP4 gene alleles among human rotaviruses recovered over a 10-year period (1982-1991) from Japanese children with diarrhea.

Authors:  S Gunasena; O Nakagomi; Y Isegawa; E Kaga; T Nakagomi; A D Steele; J Flores; S Ueda
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

8.  Determination of human rotavirus VP4 using serotype-specific cDNA probes.

Authors:  N B Rasool; G Larralde; M I Gorziglia
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 9.  Development of candidate rotavirus vaccines.

Authors:  R F Bishop
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

10.  Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children.

Authors:  R L Ward; M M McNeal; D S Sander; H B Greenberg; D I Bernstein
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more
  4 in total

1.  Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico.

Authors:  L Padilla-Noriega; M Méndez-Toss; G Menchaca; J F Contreras; P Romero-Guido; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; J Calva; M L Guerrero; B S Coulson; H B Greenberg; S López; C F Arias
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

2.  Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types).

Authors:  P J Masendycz; E A Palombo; R J Gorrell; R F Bishop
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

Authors:  G Menchaca; L Padilla-Noriega; M Méndez-Toss; J F Contreras; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; R Ward; Y Hoshino; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  VP4 and VP7 genotyping by reverse transcription-PCR of human rotavirus in mexican children with acute diarrhea.

Authors:  A Rodríguez Castillo; A V Villa; J E Ramírez González; E Mayén Pimentel; M Melo Munguía; B Díaz De Jesús; H Olivera Díaz; H García Lozano
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.